Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 24292392)

  • 1. Self-renewal as a therapeutic target in human colorectal cancer.
    Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
    Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer: targeting self-renewal of cancer stem cells in colorectal cancer-a future treatment option?
    Leake I
    Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):75. PubMed ID: 24345889
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticancer drugs: Curbing self-renewal of cancer-initiating cells.
    Crunkhorn S
    Nat Rev Drug Discov; 2014 Feb; 13(2):102. PubMed ID: 24481304
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting self-renewal, an Achilles' heel of cancer stem cells.
    Wicha MS
    Nat Med; 2014 Jan; 20(1):14-5. PubMed ID: 24398956
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
    Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X
    Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
    Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
    J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
    Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
    J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
    Nishida Y; Maeda A; Chachad D; Ishizawa J; Qiu YH; Kornblau SM; Kimura S; Andreeff M; Kojima K
    Cancer Sci; 2015 Dec; 106(12):1705-13. PubMed ID: 26450753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
    Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
    Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
    Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
    Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
    Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.
    Paquet-Fifield S; Koh SL; Cheng L; Beyit LM; Shembrey C; Mølck C; Behrenbruch C; Papin M; Gironella M; Guelfi S; Nasr R; Grillet F; Prudhomme M; Bourgaux JF; Castells A; Pascussi JM; Heriot AG; Puisieux A; Davis MJ; Pannequin J; Hill AF; Sloan EK; Hollande F
    Cancer Res; 2018 Jun; 78(11):2925-2938. PubMed ID: 29510994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
    Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
    FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.
    Ji D; Zhan T; Li M; Yao Y; Jia J; Yi H; Qiao M; Xia J; Zhang Z; Ding H; Song C; Han Y; Gu J
    Stem Cell Reports; 2018 Dec; 11(6):1506-1522. PubMed ID: 30449704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
    Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
    Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
    Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
    Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.